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3. The EV71 VLPs vaccine was prepared successfully.
Further efforts are needed to optimize the immune
process and improve immunogenicity.
OL-007 Future treatment options for multidrug
resistant and nalidixic acid resistant typhoidal
Salmonellae
F. Kaleem1 *, J. Usman1, A. Hassan1. 1National University
of Sciences and Technology, AMC, Pakistan
Introduction: Antimicrobial resistance in Salmonella species
is of grave concern. The timely appropriate management
of typhoid fever can considerably reduce both morbidity
and mortality. Since late 1980s Salmonella typhi has
developed resistance simultaneously to all the drugs used
in ﬁrst line treatment (chloramphenicol, cotrimoxazole and
ampicillin) and are known as multidrug resistant (MDR).
Fluoroquinolones are widely regarded as the most effective
drugs for the treatment of typhoid fever. Unfortunately
there are reports of treatment failure with ﬂuoroquinolones
and nalidixic acid resistance (NAR) is a marker of reduced
susceptibility to ﬂuoroquinolones. Recently, azithromycin is
being used as an alternative agent, but sporadic reports of
resistance to these antibiotics are already being reported
and third generation cephalosporins, carbapenems and
tigecycline prove to be promising alternatives.
Materials and Methods: This descriptive study was carried
out in the Department of Microbiology, Army Medical
College, National University of Sciences and Technology,
Pakistan. All the specimens received with suspicion of
typhoid fever for blood culture were dealt with standard
microbiological procedures. Typhoidal salmonellae were
isolated and were subjected to the determination of
antimicrobial sensitivity. All MDR and NAR typhoidal
salmonellae were subjected to minimum inhibitory
concentration (MIC) testing of ceftriaxone, ceﬁxime,
meropenem and tigecycline using E-test method. MIC 50
and 90 were calculated.
Results: Among 54 MDR and NAR isolates all of the isolates
had MICs well within sensitive range for all the antibiotics
used. 28 isolates were Salmonella typhi and 26 were
Salmonella paratyphi A.
Conclusion: Among cephalosporins ceﬁxime is cost effective
as well has an advantage of oral dosing option, carbapenems
and tigecycline a new gylcylcycline have good in vitro
activity against MDR and NAR typhoidal salmonellae and
they can be used as last effective resorts against such
organisms where other options lag behind.
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Bankground: To investigate the changes in expression and
function of the intestinal oligopeptide transporter, Pept1,
in indomethacin-induced acute small intestine injury in rats
and damaged Caco-2 cells after treatment of JBP485 (a
dipeptide with anti-inﬂammatory action).
Methods: The effects of JBP485 on indomethacin-induced
intestinal histological changes, MDA levels and MPO activity,
inﬂammatory mediators release and cell LDH-release were
examined. Uptakes of Gly-sar were determined by in vivo
oral administration, in situ intestinal perfusions, in vitro
everted small intestinal sac preparations and RT-PCR and
Western blot studies for determing Pept1 mRNA and protein
were utilized.
Results:
1. JBP485 decreased in MDA concentration and MPO activity
signiﬁcantly, improved inﬂammatory characteristics in
histochemistry and attenuated cell damage induced by
indomethacin.
2. The uptake of Gly-Sar by Pept1 in indomethacin-induced
rats were signiﬁcantly decreased, whereas the Gly-Sar
concentration in plasma in JBP485 treated rats were
markedly higher than indomethacin-induced rats.
3. Indomethacin caused a signiﬁcant decrease in the
expression of pept1 mRNA and protein in the small
intestine. When compared with indomethacin-induced
rats and cells, levels of Pept1 mRNA and protein were
increased after administration of JBP485.
Conclusions: JBP485 improved acute intestinal inﬂamma-
tion condition and cells damage induced by indomethacin.
The mechanism is related to decrease the inﬂammatory
mediators release and improve the expression and function
of the intestinal oligopeptide transporter (Pept1). JBP485
might be a new therapeutic agent for acute intestinal
injury.
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Background: Giardia lamblia parasite is the most common
protozoal infection in human. Concomitant Helicobacter
pylori (H. pylori) and Giardia lamblia infection is common
for their similar mode of transmission and strong correlation
to socioeconomic levels. Only few reports had described
gastric giardiasis. Our aim was to detect H. pylori and
Giardia in gastric antral mucosal biopsies from patients
with dyspepsia. The impact of both pathogens on clinical,
endoscopic and histopathogical changes was studied.
Methods: 48 patients with dyspepsia (group1) and 28 control
patients (patients undergoing esophagogastroduodenoscopy
EGD for reasons other than dyspepsia), (group 2) were
studied. Endoscopic data were reported and gastric biopsy
specimens were obtained for subsequent PCR assay for
both organisms and for histopathological and electron
microscopic examination.
Results: Endoscopic antral gastritis and duodenal lesions
were found in both groups, however, they were signiﬁcantly
more frequently in group 1 (p = 0.002 and P= 0.0005
respectively). Esophageal lesions, nodular antral gastritis,
gastric ulcers and superﬁcial corpal gastritis were found
only in group 1.
PCR detected H. pylori infection in 58% Vs 64% for group 1
and group 2 respectively (P: NS). Giardia infection was
present in 67% Vs 42% for group 1 and group 2 respectively
(P= 0.0003, Odds ratio = 2.6). Co-infection with H. pylori
and Giardia was present in 33% of group 1 Vs 36% for group 2
(P: NS).
Abnormal histologic ﬁndings were found in both groups,
however, intestinal metaplasia was found in group 1 only.
Cellular abnormalities in the form of cytoplasmic vacuoles,
mitochondrial destruction or nuclear abnormalities were
found by Electron microscopic study in infected subjects of
both groups.
Conclusion: Giardia lamblia is an important pathogen in
patients with dyspepsia in Upper Egypt. Its contribution
might be a factor in the persistence of symptoms after
H. pylori eradication.
